# Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

> **NCT05077098** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Mark Stein** · enrollment: 8 (actual)

## Conditions studied

- Recurrent Prostate Cancer

## Interventions

- **DRUG:** ADXS-504

## Key facts

- **NCT ID:** NCT05077098
- **Lead sponsor:** Mark Stein
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-12
- **Primary completion:** 2026-07
- **Final completion:** 2028-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077098, "Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05077098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*